Government News

Health services monitoring for price hike due to COVID-19 in India

  • Posted on: 9 March 2020
  • By: PharmaTutor News

Measure of public health prepardeness in respect of APIs / intermediate / KSMs which are closely monitor the production and availability of APIs and their formulations to prevent black marketing and hoarding.

Drug controller cum licensing authority, director of health services, Chandigarh are monitoring for availability of APIs and drugs in context of outbreak of COVID-19 in China. NPPA (National Pharmaceutical pricing authority) chairman had written a letter to Drug Controller, Chandigarh and all the other State's/ UTs Chief Secretaries for taking measures on price control due to COVID-19 outbreak in the country.

Indian Government restricted export of Paracetamol and other medication due to COVID-19 outbreak

  • Posted on: 4 March 2020
  • By: PharmaTutor News

The Government has made amendments in the export policy and restricted export of specified APIs (Active Pharmaceutical Ingredients) and formulations made from 13 APIs for safety purpose due to COVID-19 outbreak in India. A notification issued by Directorate General of Foreign Trade, Commerce and Industry says that the restrictions will come into immediate effect and until further orders.

FICCI suggests India need epharmacy rules

  • Posted on: 17 January 2020
  • By: admin

e-Pharmacies strictly do not accept orders for habit forming medicines, narcotics, or any other sensitive medicines. Additionally, given the importance of the e-Pharmacy sector globally, several large investors have recently reached out to the e-Pharmacy players, expressing concern about the general investment and regulatory climate in India

Do not prescribe Nimesulide under 12 years of age, urges PvPI

  • Posted on: 3 January 2020
  • By: PharmaTutor News

Pharmacovigilance Programme of India (PvPI) urges healthcare professionals to take require measures and do not prescribe Nimesulide for children under 12 years of age. PvPI urges to spread awareness among healthcare professionals to take all necessary precautions in order to avoid such mishappenings and to promote rational use of medicines.

Indian Pharmacopoeia officially recognised at Afghanistan

  • Posted on: 26 December 2019
  • By: PharmaTutor News

Indian Pharmacopoeia has been recognised formally by the National Department of Regulation of Medicines and Health Products of the Ministry of Public Health of Islamic Republic of Afghanistan. The quality, efficacy and safety of the medicines are important from healthcare prospective. In order to ensure the quality of medicinal products, the legal and scientific standards are provided by Indian Pharmacopoeia Commission (IPC) in the form of Indian Pharmacopoeia (IP).